MARK V GODIKSEN M.D. NPI 1760518245

NPI Details

Mark V Godiksen, M.D. is an internal medicine in Clovis, CA with 40 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Mark V Godiksen, M.D. NPI is 1760518245. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Graduation Year:1986

The provider's business location address is:

688 MEDICAL CENTER DR E
SUITE 106
CLOVIS, CA
ZIP 93611-807
Phone: (559) 297-8604
Fax: (559) 297-0625

The NPI 1760518245 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Hemoglobin a1c level (HCPCS:83036)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Automated urinalysis test (HCPCS:81003)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Blood test, clotting time (HCPCS:85610)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Punch biopsy, first skin growth (HCPCS:11104)
• Injection, sotrovimab, 500 mg (HCPCS:Q0247)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)

The enumeration date for this NPI number is 2/26/2007 and was last updated on 6/18/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.